Mapping the Synthetic Biology Industry: Implications for Biosecurity

Health Secur. 2019 Sep/Oct;17(5):403-406. doi: 10.1089/hs.2019.0078.

Authors

Sarah Carter¹, Diane DiEuliis²

Affiliations

¹ Sarah R. Carter, PhD, is a Principal at Science Policy Consulting, LLC, Arlington, Virginia.
² Diane DiEuliis, PhD, is a Senior Research Fellow, Center for the Study of Weapons of Mass Destruction, National Defense University, Washington, DC.

PMID: 31593512
DOI: 10.1089/hs.2019.0078

No abstract available

MeSH terms

Biotechnology / trends
Government Regulation
Humans
Industry / trends
Interviews as Topic
Security Measures / standards*
Stakeholder Participation
Synthetic Biology*
United States
United States Dept. of Health and Human Services